Sandra Levy
ARTICLES BY THIS AUTHOR
- 4/3/2022
Hy-Vee dietitians to host blood sugar management events throughout April
Free A1C screenings will be administered at select Hy-Vee stores throughout the month. - 4/3/2022
Rite Aid offers free COVID-19 tests to Medicare beneficiaries
Medicare Part B will cover up to eight over-the-counter COVID-19 tests each month. - 3/31/2022
ViiV Healthcare receives FDA OK for new indication of Cabenuva
The expanded indication for the first and only complete long-acting HIV regimen provides an option with as few as six dosing days per year for virologically suppressed young people living with HIV. - 3/31/2022
Novo Nordisk receives FDA approval for higher-dose Ozempic
Ozempic will be available in 0.5 mg, 1 mg and 2 mg to help people with Type 2 diabetes reach their blood sugar (A1C) goal, including those with a higher A1C who have been unable to meet their A1C target. - 3/30/2022
NACDS urges administration, Congress for funding to sustain equity-driven COVID-19 response
The New York Times, ABC News and Fortune recently quoted NACDS on the issue, underscoring its message that inaction at this pivotal time could set the nation back, leave the nation less prepared and cost the nation more lives. - 3/29/2022
Meijer to kick off first sustainability supplier summit
Meijer merchants are targeting 38 different certifications on vendor products or their manufacturing and procurement processes. - 3/29/2022
FDA gives Antares Pharma OK for Tlando
Tlando is an oral treatment for testosterone replacement therapy indicated for conditions associated with a deficiency or absence of endogenous testosterone or hypogonadism in adult males. - 3/28/2022
Aurobindo receives FDA nod for 2 generics
The company obtained approval for bromfenac ophthalmic solution and clobazam oral suspension. - 3/28/2022
Pfizer, BioNTech obtain EU authorization for 2nd COVID-19 booster
The FDA authorized a second booster dose in adults aged 50 years old and older and for those aged 12 years old and older with compromised immune systems. - 3/28/2022
CVS Health to invest $18.4M in Fresno Housing development
CVS Health will invest an estimated $18.4 million into the Arthur @ Blackstone, a new Fresno Housing development planning to break ground this spring.
